Mid Atlantic Financial Management’s Zimmer Biomet ZBH Stock Holding History

Mid Atlantic Financial Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,010	Closed	-$312K	–	961
2021 Q1	$312K	Sell	2,010 -328	-14%	-$50.8K	0.02%	612
2020 Q4	$350K	Buy	2,338 +471	+25%	+$66.5K	0.03%	518
2020 Q3	$283K	Buy	1,867 +1	+0.1%	+$131	0.02%	541
2020 Q2	$216K	Sell	1,866 -213	-10%	-$24.5K	0.02%	607
2020 Q1	$204K	Sell	2,079 -66	-3%	-$8.65K	0.02%	563
2019 Q4	$312K	Sell	2,145 -852	-28%	-$118K	0.03%	517
2019 Q3	$400K	Sell	2,997 -888	-23%	-$115K	0.04%	419
2019 Q2	$444K	Sell	3,885 -134	-3%	-$15.7K	0.05%	403
2019 Q1	$498K	Sell	4,019 -79	-2%	-$8.98K	0.05%	362
2018 Q4	$413K	Buy	+4,098	New	+$461K	0.05%	381

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Mid Atlantic Financial Management's ZBH Position: Q2 2021 in Review

Mid Atlantic Financial Management sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 2,010 shares — an estimated $312K sold.

Mid Atlantic Financial Management first reported a position in ZBH in Q4 2018 and held it in 10 quarters. The position peaked at $498K in Q1 2019. 1,019 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

Mid Atlantic Financial Management reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
Mid Atlantic Financial Management sold 2,010 Zimmer Biomet shares in Q2 2021, an estimated $312K.
Mid Atlantic Financial Management first reported a position in Zimmer Biomet in Q4 2018 and held it in 10 quarters.
Mid Atlantic Financial Management's Zimmer Biomet position peaked at $498K in Q1 2019.
1,019 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q2 2021, filed 10 Aug 2021.